<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We describe four pediatric patients with <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> and cerebral sinovenous <z:mp ids='MP_0005048'>thrombosis</z:mp> and review the pediatric and adult literature on the treatment of sinovenous <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> of our patients had <z:hpo ids='HP_0002315'>headache</z:hpo> as the initial complaint with <z:hpo ids='HP_0003674'>onset</z:hpo> during an <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> flare </plain></SENT>
<SENT sid="2" pm="."><plain>Evaluation for <z:e sem="disease" ids="C0398623" disease_type="Disease or Syndrome" abbrv="">hypercoagulable states</z:e> revealed heterozygosity for prothrombin gene mutation and increased <z:chebi fb="0" ids="17230">homocysteine</z:chebi> level in one patient and mild elevation of anticardiolipin antibodies in two patients </plain></SENT>
<SENT sid="3" pm="."><plain>Treatment in the <z:hpo ids='HP_0011009'>acute</z:hpo> period included thrombolysis, <z:chebi fb="5" ids="28304">heparin</z:chebi>, and low-molecular-weight <z:chebi fb="5" ids="28304">heparin</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0011010'>Chronic</z:hpo> therapy included <z:chebi fb="8" ids="10033">warfarin</z:chebi>, low-molecular-weight <z:chebi fb="5" ids="28304">heparin</z:chebi>, and aspirin </plain></SENT>
<SENT sid="5" pm="."><plain>Peripheral vein <z:mp ids='MP_0005048'>thrombosis</z:mp> occurred in two patients while not on antiplatelet or anticoagulation therapy </plain></SENT>
<SENT sid="6" pm="."><plain>Neurologic outcome was positive in this series without complications of therapy, suggesting that aggressive therapy should be considered </plain></SENT>
<SENT sid="7" pm="."><plain>Although anticoagulation therapy of sinovenous <z:mp ids='MP_0005048'>thrombosis</z:mp> is controversial, particularly in the context of intestinal <z:mp ids='MP_0001914'>hemorrhage</z:mp>, it can be beneficial given the possibility of an ongoing <z:e sem="disease" ids="C0398623" disease_type="Disease or Syndrome" abbrv="">hypercoagulable state</z:e> </plain></SENT>
</text></document>